The present invention relates to the field of anti-inflammatory substances, and more particularly to novel compounds that act as antagonists of the mammalian adhesion proteins known as selectins. In some embodiments, methods for treating selectin mediated disorders are provided which include administration of compound of Formula I: ##STR00001## wherein the constituent variables are defined herein.

 
Web www.patentalert.com

< Methods for detecting TAFIa or TAFIai

> Methods and compositions for selectin inhibition

~ 00489